Pharmabiz8m
OC Academy survey indicates 93.58% of Indian doctors demand specialized upskilling beyond CME
OC Academy survey indicates 93.58% of Indian doctors demand specialized upskilling beyond CME: Our Bureau, Bengaluru Wednesday, October 23, 2024, 16:40 Hrs [IST] OC Academy has in ...
Pharmabiz3h
Modern HR technology reshaping workforce management for healthcare providers: Srinivas Bhararthy
The healthcare industry stands apart in its complexity and stakes—where every decision, every action can be a matter of life ...
Pharmabiz48m
Asahi Kasei Medical launches Planova FG1 next-generation virus removal filter
Asahi Kasei Medical launches Planova FG1 next-generation virus removal filter: Düsseldorf, Tokyo Wednesday, October 23, 2024, 16:00 Hrs [IST] Asahi Kasei Medical has launched the ...
Pharmabiz1h
Oblique Therapeutics enters research collaboration pact with Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target
Oblique Therapeutics enters research collaboration pact with Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target: Stockholm, Sweden Wednesday, ...
Pharmabiz2h
EMA committee recommends approval of LINDIS Biotech’s Korjuny to treat malignant ascites MA in adults with EpCAM-positive carcinomas
EMA committee recommends approval of LINDIS Biotech’s Korjuny to treat malignant ascites MA in adults with EpCAM-positive carcinomas: Munich, Germany Wednesday, October 23, 2024 ...
Pharmabiz4h
Nuclidium announces first patient imaged in phase 1 study evaluating 61Cu-based radiotracer in patients with PSMA-positive
Nuclidium announced that the first patient has been successfully imaged in a phase 1 clinical trial evaluating the company’s radiotracer candidate as a safe and accurate diagnostic and disease-staging ...
Pharmabiz3h
Nucleus RadioPharma expands radiopharmaceutical research, development and manufacturing capacity
Nucleus RadioPharma expands radiopharmaceutical research, development and manufacturing capacity: Rochester, Minnesota Wednesday, October 23, 2024, 13:00 Hrs [IST] Nucleus RadioPh ...
Pharmabiz5h
EMA committee recommends extended authorization for BeiGene’s Tevimbra to treat gastric or gastroesophageal junction cancer & ESCC
EMA committee recommends extended authorization for BeiGene’s Tevimbra to treat gastric or gastroesophageal junction cancer & ESCC: San Mateo, California Wednesday, October 23, ...
Pharmabiz6h
US FDA clears HELP Therapeutics’ IND application for universal iPSC-derived HiCM-188 cell therapy to treat end-stage heart failure
US FDA clears HELP Therapeutics’ IND application for universal iPSC-derived HiCM-188 cell therapy to treat end-stage heart failure: Nanjing, China Wednesday, October 23, 2024, 1 ...
Pharmabiz7h
Samsung Biologics inks largest manufacturing deal with Asia-based pharma company
Samsung Biologics inks largest manufacturing deal with Asia-based pharma company: Incheon, S. Korea Wednesday, October 23, 2024, 09:00 Hrs [IST] Samsung Biologics, a global contra ...
Pharmabiz8h
Anticipating notification, TN IPGA starts training programme for drug inspector and medical devices officer exams
Anticipating notification, TN IPGA starts training programme for drug inspector and medical devices officer exams: Peethaambaran Kunnathoor, Chennai Wednesday, October 23, 2024, 0 ...
Pharmabiz8h
India and Germany to advance translational research in neurosciences with focus on pain management
India and Germany to advance translational research in neurosciences with focus on pain management: Nandita Vijayasimha, Bengaluru Wednesday, October 23, 2024, 08:00 Hrs [IST] Ind ...